Neuroendocrine Neoplasm — Trials

Neuroendocrine Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

2,395 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 601–650 of 2,395 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07050472	Durvalumab After Concurrent Chemoradiotherapy (cCRT) for Limited-stage Small-cell Lung Cancer (LS-SCLC)	completed	—	45	Anhui Shi, MDOTHER	1	Feb 12, 2026	clinicaltrials
NCT06937905	Tarlatamab vs Standard of Care Chemotherapy in Patients With Pre-treated Advanced, Pulmonary or Gastroenteropancreatic Poorly Differentiated Neuroendocrine Carcinomas (NECs)(TARLANEC)	recruiting	Phase 3	129	Intergroupe Francophone de Cancerologie ThoraciqueOTHER